The AXMAZAN brand, founded in 2014 (United Kingdom), from 1722 sister brands and 17477 competing brands. The AXMAZAN brand is owned by GSK PLC, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. The sector of AXMAZAN is Drug Manufacturers.